单细胞传感器分析揭示了信号程序,使Ras-G12C具有耐药性
Jason Z Zhang1,2,3, Shao-En Ong4, David Baker5,6,7
1Department of Biochemistry, University of Washington, Seattle, WA, USA. jason.zhang0428@gmail.com.
Nature chemical biology
|August 5, 2024
概括
对KRas-G12C抑制剂的临床耐药性是一个挑战. 单细胞分析揭示了耐药癌细胞的适应信号和代谢变化,确定了主要的密室蛋白质作为关键调解者.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 细胞信号传递 细胞信号传递
背景情况:
- 对大鼠肉瘤病毒 (Ras) -G12C抑制剂的临床耐药性在癌症治疗中构成了重大挑战.
- 对于这些药物的反应,对单细胞水平上Ras信号的直接适应效应尚不清楚.
研究的目的:
- 描述内源Ras在单细胞水平对Ras-G12C抑制剂的反应中的活性和信号环境.
- 了解导致药物耐药性的适应性信号和代谢变化.
主要方法:
- 利用Ras生物传感器进行内源Ras活动的单细胞水平分析.
- 在接受Ras-G12C抑制剂治疗的KRas-G12C细胞中分析了信号传递和代谢适应.
主要成果:
- 确定了KRas-G12C细胞的一个亚群,表现出适应性信号和代谢变化.
- 观察到野生型Ras在Golgi和突变KRas在线粒体中介抗性的不同作用.
- 通过脚手架信号组件和代谢道发现主要的顶蛋白作为Ras激活的调解者.
结论:
- 单细胞分析方法可以揭示细胞对癌症治疗的适应性,并提供对药物耐药性机制的见解.
- 了解这些适应,包括主要密室蛋白的作用,对于克服对Ras-G12C抑制剂的耐药性至关重要.
更多相关视频
14:51Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype
Published on: June 17, 2022
3.2K
08:46Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
Published on: December 9, 2015
10.6K
相关概念视频
The Ras Gene
6.2K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
6.2K
Small GTPases - Ras and Rho
3.9K
Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Three regulatory proteins control their activity:
3.9K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Interactions Between Signaling Pathways
6.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
PI3K/mTOR/AKT Signaling Pathway
3.5K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.5K
